Trial Profile
Anti-[18F]FACBC PET-CT for the Characterization of Primary Prostate Cancer
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 15 Jan 2016
Price :
$35
*
At a glance
- Drugs Fluciclovine 18F (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- 15 Jan 2016 New trial record